Molecular quality control focuses on testing of molecular diagnostic products for identification of defects and reporting these to the management, influencing the decision on whether to release the product or not. Quality control procedures for molecular testing have been widely adopted in the past few years, particularly for infectious disease tests, where quality control materials are available, tests are cleared by the FDA, published quality control protocols are available, and the tests are quantitative with limited number of analytes. Additionally, quality controls are available for some of the multiplex tests such as cystic fibrosis test.
The global molecular quality controls market is driven by rise in focus of market players on developing molecular diagnostic tests for identification of infectious diseases and detection of cancer; rise in adoption of third-party quality controls by end-users, increase in the number of accredited clinical laboratories, and surge in demand for external quality assessment support. Additionally, focus of market players on product launches and partnerships to expand product portfolio and geographic presence boosts market growth. For instance, in 2018, Microbiologics launched a range of quality control products including vaginal verification panel, enteric viral control panel, blood culture control panel, and vaginal control panel. In the same year, Seracare entered into a partnership with AccuRef Diagnostics to market the latter’s portfolio of CRISPR-engineered cell line reference materials. However, unfavorable reimbursement scenario for molecular diagnostic tests, high costs associated with quality control process, and budget constraints of end-users such as hospitals and clinical laboratories are likely to hamper the growth of the molecular quality controls market.
The global molecular quality controls market can be segmented based on product, analyte type, application, end-user, and region. In terms of product, the molecular quality controls market can be bifurcated into independent control and instrument control. The instrument control segment can be classified into polymerase chain reaction instruments (PCR), next-generation sequencing (NGS), and others. Based on analyte type, the global molecular quality controls market can be categorized into single-analyte controls and multiple-analyte controls. In terms of application, the molecular quality controls market can be divided into infectious diseases, oncology, genetic testing, and others. Based on end-user, the global molecular quality controls market can be classified into clinical laboratories, hospitals, in vitro diagnostics manufacturers, contract research organizations, academic & research centers, and others.
Geographically, the global molecular quality controls market can be segmented into five major regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America was the major market for molecular quality controls in terms of revenue in 2017. The region is anticipated to continue to dominate the global molecular quality controls market during the forecast period. The U.S. was the major market in North America in terms of revenue in 2017. The market in the country is projected to grow at a rapid pace owing to rise in CLIA accreditation of clinical laboratories. Additionally, well-established health care infrastructure, increase in investments by key players in the development of advanced diagnostic procedures for cancer diagnosis and detection of infectious diseases, presence of leading players, and ease of availability of technologically advanced products boost market growth. Europe was the next leading market in terms of revenue in 2017 and is expected to sustain its position during the forecast period. Growth of the molecular quality controls market in the region is attributed to rise in the number of contract research organizations and increase in demand for third-party quality control support. The market in Asia Pacific is expected to expand at a high CAGR from 2018 to 2026, owing to increase in incidence of infectious diseases, government focus on enhancing the health care infrastructure, and focus of key players on exploiting opportunities in the emerging markets.
Leading players operating in the global molecular quality controls market are Seracare Life Sciences, Inc., Zeptometrix, Thermo Fisher Scientific, Abbott Laboratories, Bio-Rad Laboratories, Roche Diagnostics, Microbiologics, Inc., Maine Molecular Quality Controls, Inc., Quidel, Qnostics, and Theranostica, among others.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.
TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.
Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:
Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.
Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.
Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.